Antimicrob Agents Chemother
- YANG H, Yu X, Hou W, Liu X, et al
Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant
recipients with severe kidney dysfunction infected with COVID-19.
Antimicrob Agents Chemother. 2024 Jan 30:e0138423. doi: 10.1128/aac.01384.
- ZHANG R, Zhou J, Yan H, Liu X, et al
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease.
Antimicrob Agents Chemother. 2024;68:e0129723.
- MIAH M, Davis AM, Hannoun C, Said JS, et al
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor
targeting the VP1 pocket of human rhinovirus.
Antimicrob Agents Chemother. 2024;68:e0106423.
Antiviral Res
- GOTO T, Kawai N, Bando T, Takasaki Y, et al
Virological and clinical outcomes in outpatients treated with baloxavir or
neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the
2022-2023 season.
Antiviral Res. 2024;224:105853.
- SINHA D, Yaugel-Novoa M, Waeckel L, Paul S, et al
Unmasking the potential of secretory IgA and its pivotal role in protection from
respiratory viruses.
Antiviral Res. 2024 Feb 6:105823. doi: 10.1016/j.antiviral.2024.105823.
- WINIGER RR, Perez L
Therapeutic antibodies and alternative formats against SARS-CoV-2.
Antiviral Res. 2024 Jan 31:105820. doi: 10.1016/j.antiviral.2024.105820.
- BOGACHEVA MS, Kuivanen S, Potdar S, Hassinen A, et al
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
Antiviral Res. 2024 Jan 23:105813. doi: 10.1016/j.antiviral.2024.105813.
BMC Pediatr
- CUI J, Jia W, Li P, Zhang X, et al
Influenza a H1N1 infection complicated with encephalopathy and acute
pancreatitis: a case report.
BMC Pediatr. 2024;24:156.
BMJ
- WATTERSON A
What we did not learn at the covid inquiry in Scotland: a gap analysis.
BMJ. 2024;384:q491.
- AGIUS RM
UK workers during the pandemic: inadequate protection and, consequently,
increased risk.
BMJ. 2024;384:q508.
- WISE J
Covid-19 taskforce called for a new national vaccine agency to prepare for future
pandemics.
BMJ. 2024;384:q534.
Epidemiol Infect
- BIRD O, Galiza EP, Baxter DN, Boffito M, et al
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal
insight.
Epidemiol Infect. 2024;152:e37.
- WAITE LL, Nahhas A, Irvahn J, Garden G, et al
COVID-19 passenger screening to reduce travel risk and translocation of disease.
Epidemiol Infect. 2024;152:e36.
Eur J Epidemiol
- NORSTROM T, Ramstedt M
The impact of the COVID-19 pandemic on mortality in Sweden-Did it differ across
socioeconomic groups?
Eur J Epidemiol. 2024;39:137-145.
- YANG L, Chen W, Chen D, He J, et al
Cohort profile: the China surgery and anesthesia cohort (CSAC).
Eur J Epidemiol. 2024;39:207-218.
J Immunol
- READ KA, Amici SA, Farsi S, Cutcliffe M, et al
PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center
Responses during Influenza Virus Infection.
J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
J Infect Dis
- EGESKOV-CAVLING AM, Johannesen CK, Lindegaard B, Fischer TK, et al
Underreporting and Misclassification of Respiratory Syncytial Virus-Coded
Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.
J Infect Dis. 2024;229.
- SHEIKH Z, Potter E, Li Y, Cohen RA, et al
Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A
Systematic Review.
J Infect Dis. 2024;229.
- OSEI-YEBOAH R, Zhu F, Wang X, Nair H, et al
Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels
Among Children and Adults in Scotland.
J Infect Dis. 2024;229.
- KENMOE S, Chu HY, Dawood FS, Milucky J, et al
Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections
During Pregnancy.
J Infect Dis. 2024;229.
- VAN ROEKEL C, Poukka E, Turunen T, Nohynek H, et al
Effectiveness of Immunization Products Against Medically Attended Respiratory
Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control
Study.
J Infect Dis. 2024;229.
- CHAPPIN K, Besteman SB, Hennus MP, Wildenbeest JG, et al
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype
in Infants With Severe Respiratory Syncytial Virus Infection.
J Infect Dis. 2024;229.
- OSEI-YEBOAH R, Johannesen CK, Egeskov-Cavling AM, Chen J, et al
Respiratory Syncytial Virus-Associated Hospitalization in Adults With
Comorbidities in 2 European Countries: A Modeling Study.
J Infect Dis. 2024;229.
- JOHNSON M, Chelysheva I, Oner D, McGinley J, et al
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity
in Infants.
J Infect Dis. 2024;229.
- HAK SF, Venekamp RP, Billard MN, van Houten MA, et al
Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term
Infants: An International Prospective Birth Cohort Study.
J Infect Dis. 2024;229.
- LIM WW, Shuo F, Wong SS, Sullivan SG, et al
Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy
against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections.
J Infect Dis. 2024 Mar 7:jiae122. doi: 10.1093.
JAMA
- HARRIS E
Millions of US Children Experience Range of Long COVID Effects.
JAMA. 2024;331:726.
- RUBIN R
When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not
All Alike.
JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
MMWR Morb Mortal Wkly Rep
- DECUIR J, Payne AB, Self WH, Rowley EAK, et al
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines
Against COVID-19-Associated Emergency Department and Urgent Care Encounters and
Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY
Networks,
MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
- ESSER MB, Sherk A, Liu Y, Naimi TS, et al
Deaths from Excessive Alcohol Use - United States, 2016-2021.
MMWR Morb Mortal Wkly Rep. 2024;73:154-161.
Pediatrics
- YONTS AB, Gaviria-Agudelo C, Kimberlin DW, O'Leary ST, et al
Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric
Vaccines.
Pediatrics. 2023 Dec 14. doi: 10.1542/peds.2023-064990.
- CURNS AT, Rha B, Lively JY, Sahni LC, et al
Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years
Old: 2016 to 2020.
Pediatrics. 2024;153:e2023062574.
- VANDERMORRIS A, Toulany A, McKinnon B, Tam MW, et al
Sexual and Reproductive Health Outcomes Among Adolescent Females During the
COVID-19 Pandemic.
Pediatrics. 2024;153:e2023063889.
- GRUBB LK
Sexual and Reproductive Health During the Pandemic: Vulnerable Populations Are
Hit the Hardest.
Pediatrics. 2024;153:e2023064523.
- RAO S, Gross RS, Mohandas S, Stein CR, et al
Postacute Sequelae of SARS-CoV-2 in Children.
Pediatrics. 2024;153:e2023062570.
- CARDEMIL CV, Cao Y, Posavad CM, Badell ML, et al
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Pediatrics. 2024 Feb 9:e2023064252. doi: 10.1542/peds.2023-064252.
- AHMED A, Munoz FM, Muller WJ, Agwu A, et al
Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
Pediatrics. 2024;153:e2023063775.
- FRINTNER MP, Leslie LK, Gottschlich EA, Starmer AJ, et al
Pediatricians' Career Satisfaction and Wellbeing by Sex Before and During the
COVID-19 Pandemic.
Pediatrics. 2024;153:e2023063345.
- CHUA KP, Volerman A, Zhang J, Hua J, et al
Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.
Pediatrics. 2024;153:e2023064245.
PLoS Med
- MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in
ethnic minorities: A nationwide register-linked cohort study in Denmark.
PLoS Med. 2024;21:e1004280.
PLoS One
- MANACAS LRA, Amorim RLO, Aguila A, Novo PC, et al
Evaluation of hematological changes and immune response biomarkers as a
prognostic factor in critical patients with COVID-19.
PLoS One. 2024;19:e0297490.
- MADRAZO L, Choo-Foo J, Domecq MC, LaDonna KA, et al
Illness presenteeism among physicians and trainees: Study protocol of a scoping
review.
PLoS One. 2024;19:e0297447.
- CONOLLY AR, Maben J, Abrams R, Harris R, et al
'There was a pivotal moment'. The dynamics, transitions, adaptations and
trajectories of nursing at the front-line in the UK during the COVID-19 pandemic.
PLoS One. 2024;19:e0295394.
- HEDDEN L, Spencer S, Mathews M, Gard Marshall E, et al
"Technology has allowed us to do a lot more but it's not necessarily the panacea
for everybody": Family physician perspectives on virtual care during the COVID-19
pandemic and beyond.
PLoS One. 2024;19:e0296768.
- SEALE H, Harris-Roxas B, Heywood AE, Abdi I, et al
"It's no use saying it in English": A qualitative study exploring community
leaders' perceptions of the challenges and opportunities with translating and
interpreting COVID-19 related public health messaging to reach ethnic minorities
in Australia.
PLoS One. 2024;19:e0284000.
- BRESSER M, Erhardt RM, Shanaube K, Simwinga M, et al
Evaluation of COVID-19 antigen rapid diagnostic tests for self-testing in Lesotho
and Zambia.
PLoS One. 2024;19:e0280105.
- PRADO ADS, Baldofski S, Kohls E, Rummel-Kluge C, et al
International and domestic university students' mental health over the course of
the COVID-19 pandemic in Germany: Comparison between 2020, 2021, and 2022.
PLoS One. 2024;19:e0299812.
- HOOKHAM L, Cantrell L, Cose S, Freyne B, et al
Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in
Uganda and Malawi.
PLoS One. 2024;19:e0290913.
- CHARQUERO-BALLESTER M, Walter JG, Rybner AS, Nissen IA, et al
Emotions on Twitter as crisis imprint in high-trust societies: Do ambient
affiliations affect emotional expression during the pandemic?
PLoS One. 2024;19:e0296801.
- BUMYUT A, Thanapop S, Dwipayanti NMU
Safety and health measures compliance during the COVID-19 pandemic for
community-based tourism in Nakhon Si Thammarat, Thailand: A cross-sectional
descriptive study.
PLoS One. 2024;19:e0300030.
- LWIN MO, Sheldenkar A, Tng PL
You must be myths-taken: Examining belief in falsehoods during the COVID-19
health crisis.
PLoS One. 2024;19:e0294471.
- CRUICKSHANK M, Brazzelli M, Manson P, Torrance N, et al
What is the impact of long-term COVID-19 on workers in healthcare settings? A
rapid systematic review of current evidence.
PLoS One. 2024;19:e0299743.
- DOMNICH A, Calabro GE
Epidemiology and burden of respiratory syncytial virus in Italian adults: A
systematic review and meta-analysis.
PLoS One. 2024;19:e0297608.
- KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
Minimal change disease following COVID-19 vaccination: A systematic review.
PLoS One. 2024;19:e0297568.
- GROSSMANN K, Risch M, Markovic A, Aeschbacher S, et al
Sex-specific differences in physiological parameters related to SARS-CoV-2
infections among a national cohort (COVI-GAPP study).
PLoS One. 2024;19:e0292203.
- SOW MS, Togo J, Simons LM, Diallo ST, et al
Genomic characterization of SARS-CoV-2 in Guinea, West Africa.
PLoS One. 2024;19:e0299082.
- HU X, Zhu B, Zhang B, Zeng L, et al
Extreme risk spillovers between US and Chinese agricultural futures markets in
crises: A dependence-switching copula-CoVaR model.
PLoS One. 2024;19:e0299237.
- OCANA GUTIERREZ VR, Gonzalez Ramirez RA, Ocana Aguilar VA, Ocana Aguilar NG, et al
The weekly P25 of the age of the influenza-like illness shows a higher
correlation with COVID-19 mortality than rapid tests and could predict the
evolution of COVID-19 pandemics in sentinel surveillance, Piura, Peru, 2021.
PLoS One. 2024;19:e0295309.
Proc Natl Acad Sci U S A
- KRETSCH RC, Xu L, Zheludev IN, Zhou X, et al
Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and
related coronaviruses.
Proc Natl Acad Sci U S A. 2024;121:e2320493121.
Virus Res
- ZHANG S, Wang P, Shi L, Wang C, et al
Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
Virus Res. 2024;342:199341.
- MONTENEGRO AFL, Clementino MAF, Yaochite JNU
Type I interferon pathway genetic variants in severe COVID-19.
Virus Res. 2024;342:199339.
- LIM T, Rajoriya S, Kim B, Natasha A, et al
In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted
reactive oxygen species scavenger, against severe acute respiratory syndrome
coronavirus 2 and multiple zoonotic viruses.
Virus Res. 2024;342:199325.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016